These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30267862)

  • 21. Occurrence of Colorectal Cancer and the Influence of Medical Treatment in Patients With Inflammatory Bowel Disease: A Danish Nationwide Cohort Study, 1997 to 2015.
    Weimers P; Ankersen DV; Løkkegaard ECL; Burisch J; Munkholm P
    Inflamm Bowel Dis; 2021 Oct; 27(11):1795-1803. PubMed ID: 33409534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
    Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.
    Jess T; Simonsen J; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M
    Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature.
    Wang R; Leong RW
    World J Gastroenterol; 2014 Jul; 20(27):8783-9. PubMed ID: 25083052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory Bowel Disease-Associated Colorectal Cancer Epidemiology and Outcomes: An English Population-Based Study.
    Birch RJ; Burr N; Subramanian V; Tiernan JP; Hull MA; Finan P; Rose A; Rutter M; Valori R; Downing A; Morris EJA
    Am J Gastroenterol; 2022 Nov; 117(11):1858-1870. PubMed ID: 36327438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-analysis.
    Singh S; Edakkanambeth Varayil J; Loftus EV; Talwalkar JA
    Liver Transpl; 2013 Dec; 19(12):1361-9. PubMed ID: 24019127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The epidemiology of inflammatory bowel disease.
    Burisch J; Munkholm P
    Scand J Gastroenterol; 2015 Aug; 50(8):942-51. PubMed ID: 25687629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
    Fraga M; Fournier N; Safroneeva E; Pittet V; Godat S; Straumann A; Nydegger A; Vavricka SR; Moradpour D; Schoepfer AM;
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):91-97. PubMed ID: 27622999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.
    Baars JE; Kuipers EJ; van Haastert M; Nicolaï JJ; Poen AC; van der Woude CJ
    J Gastroenterol; 2012 Dec; 47(12):1308-22. PubMed ID: 22627504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies.
    Lutgens MW; van Oijen MG; van der Heijden GJ; Vleggaar FP; Siersema PD; Oldenburg B
    Inflamm Bowel Dis; 2013; 19(4):789-99. PubMed ID: 23448792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases.
    Rocha HC; Vilela EG
    Gastroenterol Hepatol; 2022 Feb; 45(2):83-90. PubMed ID: 34023469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of inflammatory bowel disease in first-degree relatives with risk of colorectal cancer: A nationwide case-control study in Sweden.
    Wang K; Olén O; Emilsson L; Khalili H; Halfvarson J; Song M; Ludvigsson JF
    Int J Cancer; 2023 Jun; 152(11):2303-2313. PubMed ID: 36760205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Barberio B; Massimi D; Cazzagon N; Zingone F; Ford AC; Savarino EV
    Gastroenterology; 2021 Dec; 161(6):1865-1877. PubMed ID: 34425093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
    Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn's disease: a nationwide population-based cohort study.
    Ording AG; Horváth-Puhó E; Erichsen R; Long MD; Baron JA; Lash TL; Sørensen HT
    Inflamm Bowel Dis; 2013; 19(4):800-5. PubMed ID: 23435402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal Dysplasia and Cancer in Pediatric-Onset Ulcerative Colitis Associated With Primary Sclerosing Cholangitis.
    El-Matary W; Guthery SL; Amir AZ; DiGuglielmo M; Draijer LG; Furuya KN; Gupta N; Hochberg JT; Horslen S; Kerkar N; Koot BGP; Laborda TJ; Loomes KM; Mack C; Martinez M; Miethke A; Miloh T; Mogul D; Mohammed S; Moroz S; Ovchinsky N; Perito ER; Rao G; Ricciuto A; Sathya P; Schwarz KB; Shah U; Singh R; Soufi N; Valentino PL; Zizzo A; Deneau MR
    Clin Gastroenterol Hepatol; 2021 May; 19(5):1067-1070.e2. PubMed ID: 32360820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease.
    Lutgens M; Vermeire S; Van Oijen M; Vleggaar F; Siersema P; van Assche G; Rutgeerts P; Oldenburg B;
    Clin Gastroenterol Hepatol; 2015 Jan; 13(1):148-54.e1. PubMed ID: 25041864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis.
    Wijnands AM; de Jong ME; Lutgens MWMD; Hoentjen F; Elias SG; Oldenburg B;
    Gastroenterology; 2021 Apr; 160(5):1584-1598. PubMed ID: 33385426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I).
    Sebastian S; Hernández V; Myrelid P; Kariv R; Tsianos E; Toruner M; Marti-Gallostra M; Spinelli A; van der Meulen-de Jong AE; Yuksel ES; Gasche C; Ardizzone S; Danese S
    J Crohns Colitis; 2014 Jan; 8(1):5-18. PubMed ID: 23664897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rates and characteristics of postcolonoscopy colorectal cancer in the Swedish IBD population: what are the differences from a non-IBD population?
    Stjärngrim J; Ekbom A; Hammar U; Hultcrantz R; Forsberg AM
    Gut; 2019 Sep; 68(9):1588-1596. PubMed ID: 30554159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.